Across TCGA pan-cancer cohorts, UNC119 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated UNC119 data layer compared with 24 for mass-spec protein and 4 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher UNC119 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated UNC119 expression acts as an unfavorable survival marker, although some lineages such as UCEC and PDAC show a favorable association.
UCEC, CCRCC, and GBM are the cancer types where UNC119 mass-spec protein most reproducibly stratifies survival.